Brawn Biotech
Brawn Biotech Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Brawn Biotech
Start SIPBrawn Biotech Investment Rating
-
Master Rating:
-
Brawn Biotech has an operating revenue of Rs. 21.27 Cr. on a trailing 12-month basis. An annual revenue growth of 158% is outstanding, Pre-tax margin of -2% needs improvement, ROE of -13% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It is currently FORMING a base in its weekly chart and is trading around 21% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 13 which is a POOR score indicating inconsistency in earnings, a RS Rating of 25 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 64 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 3 | 7 | 5 | 6 | 8 | 3 | 3 |
| Operating Expenses Qtr Cr | 3 | 7 | 5 | 6 | 8 | 3 | 3 |
| Operating Profit Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 0 | 0 | -1 | 0 | 0 | 0 | 1 |
Brawn Biotech Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹18.35
- 50 Day
- ₹18.41
- 100 Day
- ₹18.20
- 200 Day
- ₹18.15
- 20 Day
- ₹17.87
- 50 Day
- ₹19.20
- 100 Day
- ₹17.70
- 200 Day
- ₹18.10
Brawn Biotech Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 19.42 |
| Second Resistance | 19.42 |
| Third Resistance | 19.42 |
| RSI | 56.36 |
| MFI | 66.52 |
| MACD Single Line | -0.20 |
| MACD | 0.03 |
| Support | |
|---|---|
| First Resistance | 19.42 |
| Second Resistance | 19.42 |
| Third Resistance | 19.42 |
Brawn Biotech Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 1,222 | 122,200 | 100 |
| Week | 1,872 | 187,150 | 100 |
| 1 Month | 1,144 | 114,405 | 100 |
| 6 Month | 1,417 | 141,704 | 100 |
Brawn Biotech Result Highlights
Brawn Biotech Synopsis
BSE-Medical-Generic Drugs
Brawn Biotech is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 22.23 Cr. and Equity Capital is Rs. 3.00 Cr. for the Year ended 31/03/2023. Brawn Biotech Ltd. is a Public Limited Listed company incorporated on 07/11/1985 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1985PLC022468 and registration number is 022468.| Market Cap | 6 |
| Sales | 21 |
| Shares in Float | 0.14 |
| No of funds | 5 |
| Yield | 3.13 |
| Book Value | 0.92 |
| U/D Vol ratio | 0.4 |
| LTDebt / Equity | |
| Alpha | 0.07 |
| Beta | -0.02 |
Brawn Biotech
| Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
|---|---|---|---|---|
| Promoters | 53.72% | 53.72% | 53.72% | 53.72% |
| Mutual Funds | 0.59% | 0.59% | 0.59% | 0.59% |
| Individual Investors | 42.89% | 42.87% | 42.7% | 42.44% |
| Others | 2.8% | 2.82% | 2.99% | 3.25% |
Brawn Biotech Management
| Name | Designation |
|---|---|
| Mr. Brij Raj Gupta | Chairman |
| Mrs. Brij Bala Gupta | Director |
| Mr. Subhash Chander | Independent Director |
| Mrs. Kanta Takkar | Independent Director |
Brawn Biotech Forecast
Price Estimates
Brawn Biotech Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-11-10 | Quarterly Results | |
| 2023-08-09 | Quarterly Results | |
| 2023-05-29 | Audited Results | |
| 2023-02-14 | Quarterly Results | |
| 2022-11-12 | Quarterly Results |
Brawn Biotech FAQs
What is Share Price of Brawn Biotech ?
Brawn Biotech share price is ₹19 As on 02 December, 2023 | 21:17
What is the Market Cap of Brawn Biotech ?
The Market Cap of Brawn Biotech is ₹5.8 Cr As on 02 December, 2023 | 21:17
What is the P/E ratio of Brawn Biotech ?
The P/E ratio of Brawn Biotech is -4.7 As on 02 December, 2023 | 21:17
What is the PB ratio of Brawn Biotech ?
The PB ratio of Brawn Biotech is 0.9 As on 02 December, 2023 | 21:17